IDXX monthly performance report
Monthly IDXX research: returns, drawdown, relative strength, seasonality, and key stats.
IDXX monthly report
—
Key takeaways
- Idexx Laboratories (IDXX) closed August 2026 at $584.78, up 4.60% for the month and −8.90% over the trailing 12 months.
- Year-to-date, IDXX is −13.56%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −5.87% versus its 200-day moving average ($621.28), a cautious technical signal.
- Over the past three years, IDXX has underperformed the S&P 500 by −56.28%, with a relative strength index reading of 67.4.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Idexx Laboratories ended August 2026 at $584.78, posting a monthly return of +4.60%. The S&P 500 returned +3.05% over the same window, leaving relative performance at +1.55%.
The current quarter stands at +1.41% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −5.87% versus the 200-day moving average ($621.28).
Year-to-date, IDXX is −13.56% against SPY +12.89%, a gap of −26.45%. The stock is currently −24.05% below its 52-week high, with maximum 3-year drawdown at −37.41%.
| Period | IDXX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.56% | −0.20% | −0.36% |
| 1 Week | +2.68% | +3.90% | −1.23% |
| 1 Month | +4.60% | +3.05% | +1.55% |
| 3 Months | +4.28% | +7.11% | −2.84% |
| 6 Months |